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The precise molecular events deﬁning the complex role of oxidative stress in the inactivation of the
cerebral sodium pump in radical-induced neurodegenerative diseases is yet to be fully clariﬁed and thus
still open. Herein we investigated the modulation of the activity of the cerebral transmembrane elec-
trogenic enzyme in Fe2þ-mediated in vitro oxidative stress model. The results show that Fe2þ inhibited
the transmembrane enzyme in a concentration dependent manner and this effect was accompanied by a
biphasic generation of aldehydic product of lipid peroxidation. While dithiothreitol prevented both Fe2þ
inhibitory effect on the pump and lipid peroxidation, vitamin E prevented only lipid peroxidation but not
inhibition of the pump. Besides, malondialdehyde (MDA) inhibited the pump by a mechanism not related
to oxidation of its critical thiols. Apparently, the low activity of the pump in degenerative diseases
mediated by Fe2þ may involve complex multi-component mechanisms which may partly involve an
initial oxidation of the critical thiols of the enzyme directly mediated by Fe2þ and during severe pro-
gression of such diseases; aldehydic products of lipid peroxidation such as MDA may further exacerbate
this inhibitory effect by a mechanism that is likely not related to the oxidation of the catalytically es-
sential thiols of the ouabain-sensitive cerebral electrogenic pump.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Reports have shown that the activity of Naþ/Kþ-ATPase in
many tissues and organs of mammalian systems can be profoundly
inhibited under conditions of oxidative stress related diseases.
Thus the pathophysiology, molecular and biochemical mechan-
isms underlying the reduced activity of the electrogenic enzyme in
several free-radical linked degenerative and metabolic pathologies
have been an area of intense study [1–5]. Although
Naþ/Kþ-ATPase is widely expressed in quite a number of tissues,
the transmembrane protein is mainly expressed in brain and
neuronal cells. Consequently, dysfunction of the pump has been
characterized by neuronal hyperexcitability, depolarization and
swelling [6]. Hence, the malfunctioning of the cerebral sodium
pump has been associated with some speciﬁc neurologicalB.V. This is an open access article udisorders such as diabetes, Alzheimer's disease, epilepsy and bi-
polar disorder among others. In these neurological pathologies,
constant depolarization across the cell membrane induces an im-
balance in the amount of neurotransmitters that are released
within the cell [3,4,7–10].
More importantly, it has been observed that neurological dis-
orders associated with low activity of the cerebral sodium pump
have also been characterized by increased oxidative stress indices
in the brain of such human or disease models. Thus there is an
inverse relationship between extent of oxidative stress mediated
damage and the activity of the Naþ/Kþ-ATPase in these neurolo-
gical dysfunctions [11]. However, earlier investigators have at-
tempted to unravel the underlying mechanisms that participate in
free radicals-induced dysfunction of the pump. In this regard,
emerging data led to some speculative conclusions.
Firstly, it was suggested that reactive oxygen species (ROS) may
evoke an inhibition on the enzyme indirectly. Herein, the ROS may
attack lipids in the membrane that anchor the transmembranender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
T.I. Omotayo et al. / Redox Biology 4 (2015) 234–241 235enzyme and consequently leading to an altered membrane mi-
croviscosity, which ultimately result in loss of the enzyme function
[12,13]. On the other hand, ROS have been shown to directly attack
and eventually modify amino acid residues of the enzyme thus
leading to loss of activity of the transmembrane protein [14]. Yet
some authors have speculated that aldehydic products which arise
from the lipid peroxidation process may also interact with the
transmembrane enzyme ultimately leading to its inactivation
[15,16].
Despite these ﬁndings and observations however, the precise
biochemical and molecular events that characterize free radical-
induced dysfunction of the cerebral enzyme appear complex and
far from being completely understood. Partly, the complexity
arises from the multifactorial agents and factors that mediate
oxidative stress. Therefore, in order to better understand the
molecular events associated with oxidative stress-induced in-
activation of the cerebral pump, the study of the participation of
these agents and factors must be holistic, all inclusive and total.
Evidently, unravelling these complex mechanism(s) is thus still
open.
One of the most potent neurotoxic agent that exhibit proox-
idant effect under in vitro and in vivo conditions is iron especially
Fe2þ . In fact, reports have shown that impaired iron metabolism is
an initial cause of some neurodegeneration mediated by ROS [17].
Moreso, several common genetic and sporadic neurodegenerative
disorders have been associated with dysregulated iron home-
ostasis in the central nervous system (CNS) [17]. In general, iron
accumulation causes neurodegeneration chieﬂy by inducing the
formation of free radicals which eventually damage cellular mac-
romolecules such as lipids, DNA and proteins. Furthermore, iron-
induced oxidative stress is particularly dangerous because it can
cause further iron release from iron-containing proteins such as
ferritin, heme-proteins, and Fe–S clusters, forming a destructive
intracellular positive-feedback loop that exacerbates the toxic ef-
fects of brain iron overload [17].
The harmful and deleterious effect of iron especially in the
brain has been the prime interest of researchers. Primarily, this is
because the mammalian brain is highly susceptible to free radical
attack due to high oxygen tension and a high content of poly-
unsaturated fatty acids in cell membrane phospholipids [18]. Evi-
dences suggest that iron invasion is an initial cause of neuronal
cell death and axonal degeneration [19–21]. Moreso, a cardinal
pathology associated with several common sporadic neurode-
generative disorders such as Alzheimer's disease, Parkinson's dis-
ease and Huntington's disease has been associated with iron ac-
cumulation. Findings have shown that under in vitro models re-
lating to these pathologies, there is a strong coincidence between
localized disturbed iron homeostasis and neuronal cell death in
the brain [19,20,22–26]. Furthermore, several in vivo studies of
iron regulatory proteins using transgenic rodents [27,28] have
indeed suggested that iron may be a pathogenic factor for neu-
rodegeneration. Indeed experimental evidences have suggested
that iron chelators [20,29,30] and genetic manipulation resulting
in low iron levels [29,31,32] are neuroprotective strategies against
these iron-induced neurodegenerative diseases. Other central
nervous system (CNS) disorders that have been proposed to be
associated with disturbed iron homeostasis include the Freider-
ich's Ataxia [26], Restless Leg Syndrome [33], Ischaemic/Haemor-
rhagic Stroke [34] and Multiple Sclerosis [25].
From the foregoing, it is apparent that iron-mediated ROS
production may be a suitable model in unravelling the precise
mechanisms of ROS-mediated dysfunction of the ouabain-sensi-
tive electrogenic sodium pump. Really, some authors have studied
iron-induced oxidative stress models to study the inactivation of
the cerebral pump's activity. In this regard, Rauchova and collea-
gues observed that iron-induced altered membrane ﬂuidity thusleading to the inhibition of the Naþ/Kþ-ATPase activity at the
initial process of lipid peroxidation. However, as lipid peroxidation
progresses, the inhibition of the transmembrane enzyme strongly
correlates only with the production of thiobarbituric acid reactive
species (TBARS) and conjugated dienes (CD) [11]. However, their
study is largely inconclusive and thus still open. Primarily, their
study did not take into consideration the fact that the trans-
membrane enzyme is a sulphydryl protein and thus the possibility
of a direct or indirect interaction between iron and the enzyme
was not clariﬁed and hence the need for the present study.Materials and methods
Chemicals
Adenosine triphosphate (ATP), α-tocopherol, cysteine, reduced
glutathione, dithiothreitol, thiobarbituric acid (TBA), were ob-
tained from Sigma (St. Louis, MO). All other chemicals which are of
analytical grade were obtained from standard commercial
suppliers.
Animals
Male adult Wistar rats (200–250 g) from our own breeding
colony were used. Animals were kept in separate animal cages, on
a 12-h light: 12-h dark cycle, at a room temperature of 22–24 °C,
and with free access to food and water. The animals were used
according to standard guidelines on the Care and Use of Experi-
mental Animal Resources.
Preparation of tissue homogenate
Rats were decapitated under mild ether anaesthesia and the
cerebral tissue (whole brain) was rapidly removed, placed on ice
and weighed. The brain was immediately homogenized in cold
10 mM Tris–HCl, pH 7.4 (1/10, w/v) with 10 up-and-down strokes
at approximately 1200 rev/min in a Teﬂon–glass homogenizer. The
homogenate was centrifuged for 10 min at 4000g to yield a pellet
that was discarded and a low-speed supernatant (S1).
Incubation systems for TBARS and sodium pump assays
Aliquot of S1 was used for the assays of thiobarbituric acid
reactive substances (TBARS) as well as Naþ/Kþ-ATPase activity.
For both assays the reaction mixture contained 3 mM MgCl,
125 mM NaCl, 20 mM KCl and 50 mM Tris–HCl, pH 7.4, FeSO4 (ﬁnal
concentrations range of 1–100 mM), with and without α-toco-
pherol (ﬁnal concentration, 1–100 mM) and with and without di-
thiothreitol (ﬁnal concentration, 2 mM), with or without mal-
ondialdehyde (MDA) (1–100 mM) and 100–180 mg protein in a ﬁnal
volume of 500 ml. The reaction was initiated by addition of ATP to a
ﬁnal concentration of 3.0 mM. Controls were carried out under the
same conditions with the addition of 0.1 mM ouabain. The reac-
tion mixture was incubated at 37 °C for 30 min. At the end of the
incubation time period, tubes were assayed for sodium pump ac-
tivity and TBARS production.
Assay of sodium pump
The reaction system for the assay of the activity of cerebral
Naþ/Kþ-ATPase was essentially the same as described above un-
der the section “incubation systems for TBARS and sodium pump”.
However, at the end of the incubation time period (30–60 min),
the reaction was stopped by addition of 5% trichloroacetic acid.
Released inorganic phosphorous (Pi) was measured by the method
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lated by the difference between two assays (with and without
ouabain). All the experiments were conducted at least three times
and similar results were obtained. Protein was measured by the
method of Lowry et al. [36], using bovine serum albumin as
standard.
For all enzyme assays, incubation times and protein con-
centration were chosen to ensure the linearity of the reactions. All
samples were run in duplicate. Controls with the addition of the
enzyme preparation after mixing with trichloroacetic acid (TCA)
were used to correct for non-enzymatic hydrolysis of substrates.
Enzyme activity was expressed as nmol of phosphate (Pi) released
min1 mg protein1.
Assay of TBARS
The reaction system for the assay of production of the cerebral
TBARS was essentially the same as described above under the
section “incubation systems for TBARS and sodium pump”. How-
ever, at the end of the incubation time period (30–60 min) pro-
duction of TBARS was determined as described by the method of
Ohkawa et al. [37] except that the buffer of colour reaction has a
pH of 3.4. The colour reactionwas developed by adding 200 ml 8.1%
SDS to S1, followed by sequential addition of 500 ml acetic acid/HCl
(pH 3.4) and 500 ml 0.8% of thiobarbituric acid (TBA). This mixture
was incubated at 100 °C for 1 h. TBARS produced were measured
at 532 nm and the absorbance was compared to that of a standard
curve obtained using malondialdehyde (MDA).Fig. 1. Biphasic effect of iron (II) on MDA production from cerebral tissue homogenate
combination of both 100 mM vitamin E and 2 mM DTT (panel d) on the biphasic effect i
independent experiments carried out in different days. Data were analysed using approp
results. *Signiﬁcantly lower from control; #signiﬁcantly higher than control (po0.05).Oxidation of thiols
The rate of dithiothreitol (DTT) oxidation was determined in
the presence of 50 mM Tris–HCl, pH 7.4, and varying concentration
of Fe2þ (10–100 mM). The rate of thiol oxidation was evaluated by
measuring the disappearance of –SH groups. Free –SH groups were
determined according to Ellman [38]. Incubation at 37 °C was in-
itiated by the addition of DTT (ﬁnal concentration, 2 mM). Aliquots
of the reaction mixture (100 ml) were checked (at 1 h interval for
3 h) for the amount of –SH groups at 412 nm by the addition of the
colour reagent 5′5′-dithio-bis (2-nitrobenzoic) acid (DTNB).
Statistical analysis
Results were analysed by appropriate analysis of variance
(ANOVA) and this is indicated in text of results. Duncan's Multiple
Range Test was applied. Differences between groups were con-
sidered to be signiﬁcant when po0.05.Results
Effect of Fe2þ , DTT and vitamin E on cerebral MDA production
In order to better explore the experimental results, separate
and combined analysis of variance were conducted on the ex-
perimental data. As depicted in Fig. 1 (panel a), one-way ANOVA
analysis indicate that Fe2þ elicited a biphasic effect on the pro-
duction of aldehydic product of lipid peroxidation with lower(panel a). The inﬂuence of vitamin E (100 mM) (panel b), DTT (2 mM) (panel c) and
ron (II) are shown as indicated. Data are presented as mean7SEM of at least three
riate analysis of variance followed by Duncan test as indicated in the description of
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higher concentrations of Fe2þ appear to be counteracting the
production of these aldehydic products of lipid peroxidation.
Conversely, in the presence of vitamin E, a potent antioxidant,
two-way ANOVA [(with and without vitamin E) (5 concentra-
tions of Fe2þ)], of the results obtained revealed that the produc-
tion of aldehydic products of lipid peroxidation elicited by Fe2þ
was markedly hindered (Fig. 1, panel b). However, since earlier
data has shown that DTT could protect the oxidation of thiols
especially on the cerebral sodium pump, attempt was made to
investigate the possible inhibitory effect of this dithiol on lipid
peroxidation. Similar to the result presented in Fig. 1 (panel b),
two-way ANOVA [(with and without DTT) (5 concentrations of
Fe2þ)] clearly revealed that DTT have marked inhibitory effect on
the biphasic pattern of aldehydic productions elicited by Fe2þ
(Fig. 1, panel c). The possible effect of the combination of both
vitamin E and DTT on the lipid peroxidation process was also
tested. In this regard, three-way ANOVA [(with and without
DTT) (with and without vitamin E) (5 concentrations of Fe2þ)]
clearly revealed that the lipid peroxidation process was inhibited
in the presence of vitamin E whether alone or in combination with
DTT (Fig. 1, panel d). Sufﬁce to mention that for all analysis, mean
values are considered signiﬁcant from each other when po0.05.
Effect of Fe2þ , vitamin E and DTT on cerebral Naþ /Kþ-ATPase activity
In the reaction system for the assay of the cerebral sodium
pump, the effect of increasing concentration of Fe2þ on the ac-
tivity of the pump was tested. Herein it was observed that one-
way ANOVA distinctly revealed that Fe2þ evoked a concentration-
dependent decrease in the activity of the cerebral transmembrane
sodium pump (Fig. 2, panel a). Based on this observed effect ofFig. 2. Effect of iron (II) on the activity of the cerebral sodium pump (a). The differen
combination of both vitamin E and DTT (panel d) on the activity of the cerebral sodium
three independent experiments carried out in different days. Data were analysed usi
description of results. *Signiﬁcantly lower from control; #signiﬁcantly higher than contFe2þ on the activity of the cerebral pump and considering Fig. 1a,
it is rational to speculate that lipid peroxidation process may be
linked to the observed inhibitory effect of Fe2þ on the activity of
the enzyme. Hence the possible protective effect of vitamin E, a
potent inhibitor of lipid peroxidation on the inhibitory effect of
Fe2þ on the activity of the cerebral pump was tested. Two-way
ANOVA analysis [(with and without vitamin E) (5 concentrations
of Fe2þ)] of the data obtained revealed that vitamin E had no
protective effect on Fe2þ-induced inhibition of the activity of the
cerebral pump (Fig. 2, panel b). Furthermore, since DTT has already
been documented to protect against oxidation of sulphydryl
groups of the enzyme, the possible involvement of oxidation of the
critical thiols of the enzyme as a component of its inhibition by
Fe2þ was also investigated. Two-way ANOVA [(with and without
DTT) (5 concentrations of Fe2þ)] showed that DTT exerted con-
siderable protective effect on the activity of the enzyme (Fig. 2,
panel c). In fact, three-way ANOVA (with and without vitamin E)
(with and without DTT) (5 concentrations of Fe2þ) revealed that
when both vitamin E and DTT were combined they exerted a
marked protective effect on the activity of the enzyme (Fig. 2,
panel d).Effect of vitamin E on activity of Naþ /Kþ-ATPase
The effect of increasing concentration of vitamin E on the ac-
tivity of the ouabain sensitive cerebral electrogenic pump is pre-
sented in Fig. 3. One-way ANOVA apparently revealed that the
transport function of the electrogenic pump was not affected by
the potent antioxidant.t panels shows the effect of 100 mM vitamin E (panel b), 2 mM DTT (panel c) and
pump subjected to iron (II) assault. Data are presented as mean7SEM of at least
ng appropriate analysis of variance followed by Duncan test as indicated in the
rol (po0.05).
Fig. 3. Effect of vitamin E on Naþ/Kþ-ATPase activity. Data are presented as
mean 7 SEM of three independent experiments carried out in different days. Data
were analysed using one-way ANOVA followed by Duncan test (po0.05).
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As shown in Fig. 4, the rate of DTT oxidation was increased by
Fe2þ . Two-way ANOVA (control/Fe2þ 4 sample times) or (con-
trol/4 concentrations of Fe2þ 4 sample times) revealed a sig-
niﬁcant Fe2þ versus time interaction (po0.001). In fact, the oxi-
dation of DTT was increased as a function of time in the presence
of Fe2þ .Effect of MDA on activity of Naþ /Kþ-ATPase
Fig. 5 (panel a) shows the effect of increasing concentration of
MDA on the activity of Naþ/Kþ-ATPase. One-way ANOVA indicates
that MDA inhibits the pump in a concentration dependent man-
ner. Furthermore the inhibition of the cerebral enzyme by MDA
was not markedly (po0.05) modiﬁed in the presence of DTT
(Fig. 5, panel b).0 60 12
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Fig. 4. Effects of iron on the rate of dithiothreitol oxidation. The rate of oxidation
was evaluated at the indicated times and concentrations of iron. Data are the
means of ﬁve to seven independent experiments carried out in different days. Data
are expressed as mean7SEM and post-hoc comparisons were done by Duncan's
multiple range test. *Signiﬁcant difference in relation to the control.Discussion
Excellent reports and reviews have clearly shown that the
transmembrane Naþ/Kþ-ATPase is a target in oxidative stress-
linked degenerative diseases (such as diabetes, Alzheimer diseases
etc.) in which free radicals participate in their pathophysiology
[39,40] and thus in human and animal models of these degen-
erative diseases, there is an inverse relationship between extent of
oxidative stress and activity of this important transmembrane
enzyme [41,42]. However, the precise molecular events that
characterize the role of oxidative stress in the dysfunction of the
enzyme's activity is yet to be fully clariﬁed. In any case, a deﬁnitive
answer to the molecular puzzle on the precise role of oxidative
stress in the loss of transport function of the Naþ/Kþ-ATPase in
degenerative diseases may represent a key step in the develop-
ment of the proper treatment of such diseases.
Several authors have made elegant attempts to unravel the
precise mechanisms that are involved in the pathophysiological
processes leading to the inactivation of the pump's activity under
conditions of oxidative stress. Thus far, available data clearly in-
dicate that oxidative stress mediated altered membrane dynamics
strongly correlated with altered activity of the sodium pump
[43,44]. In this regard also, the sequential molecular events that
eventually led to pump’s malfunction remain obscure and thus
experimental data may be warranted to further clarify these mo-
lecular processes.
Based on earlier ﬁndings [19,20,22–28], we decided to use an in
vitro model of Fe2þ-mediated oxidative stress to simulate possible
in vivo oxidative stress situation in the brain. In fact, iron has been
shown to react with superoxide anion (O2∙) and hydrogen peroxide
(H2O2) to produce the hydroxyl radical (OH) via the Fenton re-
action [57]. These radicals can also lead to the formation of other
reactive oxygen species (ROS) [56]. Ultimately, the overproduction
of ROS can directly attack the polyunsaturated fatty acids of the
cell membranes and induce lipid peroxidation. Hence, this model
may be ideal to study the possible correlation between oxidative
stress and the transport function of the transmembrane enzyme
under study.
Firstly, it is worthwhile mentioning that at low concentrations,
Fe2þ markedly increased the formation of aldehydic products of
lipid peroxidation which is indicated by increase in the calculated
malondialdehyde content of the brain tissue. However, at high
concentration of Fe2þ this transition metal appears to inhibit the
lipid peroxidation process (Fig. 1, panel a). This observation is a
paradox and quite intriguing. In any case, earlier authors have
suggested that when in excess, Fe2þ could compete with lipids as
electron donors for Fe O3 2+ −∙ (perferryl ion), thereby inhibiting
hydrogen abstraction and thus lipid peroxidation [45–47]. Con-
versely, there is the likelihood that the quantiﬁcation of lipid
peroxidation products using thiobarbituric acid could also detect
lipid hydroperoxides. Hence, at high iron concentrations, there is
the strong possibility that excess iron could likely decompose lipid
hydroperoxides and ultimately decrease the observed level of
thiobarbituric acid reactive substances observed in this study.
Notwithstanding, at low concentrations, Fe2þ-induced cerebral
lipid peroxidation may be an excellent model to simulate in vivo
situations involving oxidative stress assault on plasma membrane
lipids in the brain and nervous cells. The implication of the above
argument is that Fe2þ could disorganize membrane lipid bilayer
arrangement of the brain cells and leading to altered membrane
integrity and ultimately perturbed membrane ﬂuidity. Expectedly,
these series of events may lead to a parallel disorganization and
eventual loss of function of the membrane bound protein.
Consistent with the above reasoning, Fig. 2 (panel a) clearly
shows that Fe2þ inhibited the activity of the ouabain-sensitive
electrogenic pump in a concentration dependent manner. In sharp
Fig. 5. Effect of varying concentrations of MDA on the activity of Naþ/Kþ-ATPase in the absence (a) and presence of DTT (b). Data are presented as mean7SEM of three
independent experiments carried out in different days. Data were analysed using one-way ANOVA followed by Duncan test. *Signiﬁcant difference from control at po0.05.
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centrations of the transition metal exerted a more profound in-
hibitory effect on the activity of the cerebral pump. Interpretation
of this intriguing data may be complex. However, one could
speculate that at low doses, Fe2þ may ultimately generate the
highly reactive radical OH via Fenton reactions. Next the reactive
radical may assault cerebral membrane bound lipids, causing their
peroxidation and ultimately altering membrane ﬂuidity. In this
case, the structural integrity of the transmembrane pump is ad-
versely altered leading to a loss of its activity. On the other hand,
there is a strong line of evidence from the present result to suggest
that Fe2þ may bind directly to essential groups on the enzyme
thus evoking a loss of its activity. This reason is plausible con-
sidering the fact that at high concentration there was inhibition of
lipid peroxidation and yet the activity of the enzyme (Fig. 2, panel
a).
Based on the above ﬁndings, we developed some conditions to
further clarify the possible inter-relationship between of oxidative
stress and the activity of the pump. In this regard, attempt was
made to inhibit lipid peroxidation with an antioxidant agent that
would possibly not affect the activity of the pump. Herein, vitamin
E, a classical antioxidant was evaluated for its possible inhibitory
effect on the activity of the cerebral sodium pump. The result
(Fig. 3) clearly shows that this potent antioxidant when acting
alone has no effect on the activity of the transmembrane sodium
pump. With this fascinating result, this classical antioxidant was
then employed to counteract the oxidative assault evoked by Fe2þ
on brain lipids. As demonstrated in Fig. 1 (panel b), vitamin E ef-
fectively inhibited the lipid peroxidation process mediated by Fe2þ
assaults at all concentrations tested. Conversely, while this potent
antioxidant inhibited lipid peroxidation, it did not protect against
inhibitory effect of Fe2þ on the activity of the enzyme (Fig. 2, panel
b). This fact strongly suggests that in addition to inducing a per-
oxidation of cerebral lipids, the transition metal may also be in-
teracting directly with this transmembrane protein.
Therefore, based on the latter speculation above, a reaction
system was also developed to investigate the possibility of a direct
interaction between Fe2þ and the transmembrane sodium pump
that ultimately led to loss of its function. The reaction system was
developed based on previous knowledge on the structure and
function of the cerebral pump. Earlier authors and emerging data
in our laboratory have consistently demonstrated that the cerebral
sodium pump has sulphydryl groups that are critical to its activity
and that these thiols can be inhibited by oxidizing agents such as
selenium-containing compounds and inorganic mercury
[39,40,48–53]. In these reports [48,51,52], the authors observed
that these compounds oxidize critical thiol groups on the enzyme
and that endogenous thiols could prevent or relieve the inhibitionimposed on the enzyme by these thiol oxidizing compounds.
Therefore in order to explore the possibility of Fe2þ oxidizing
the catalytically important sulphhydryl groups of the cerebral so-
dium pump, an in vitro method was developed to investigate the
ability of Fe2þ to oxidize dithiothreitol alone. Interestingly, as
shown in Fig. 4, Fe2þ profoundly increased the oxidation of the
dithiol in a time dependent fashion. This observation when
translated may indicate that the toxic effect of this transition metal
on the activity of the cerebral pump may be partly linked with its
ability to oxidize essential thiols on the electrogenic pump that
may be critical to its catalytic function.
In order to verify the possible participation of the oxidation of
essential thiol on the electrogenic sodium pump by Fe2þ as a
component of its inhibitory mechanism on the pump's activity, the
incubation condition developed allowed for the pre-incubation of
dithiothreitol (DTT) with the cerebral enzyme before the assault of
Fe2þ . The data obtained (Fig. 2, panel c) shows that when DTT was
preincubated with the enzyme before the assault of Fe2þ , the di-
thiol completely prevented the inhibition of the enzyme's activity
earlier evoked by Fe2þ assault as previously observed in Fig. 2
(panel a). Intriguing as this ﬁnding may seem, it is noteworthy that
DTT also exerted a marked inhibitory effect on the lipid perox-
idation process initiated by Fe2þ (Fig. 1, panel c). As a strong re-
ductant, the mechanism by which DTT inhibited lipid peroxidation
may be partly related to its ability to reduce the transition metal.
With the above ﬁndings describing the individual effect of vi-
tamin E and the dithiol on both the activity of the cerebral sodium
pump as well as the inhibition of lipid peroxidation processes,
another incubation condition was carried to evaluate the com-
bined effect of both vitamin E and the dithiol on the lipid perox-
idation process and the activity of the pump. The results obtained
clearly show that combination of vitamin E and DTT prevented
lipid peroxidation evoked by Fe2þ (Fig. 1, panel d) and also re-
lieved the inhibitory effect of Fe2þ on the activity of the electro-
genic sodium pump (Fig. 2, panel d). From the foregoing, it is ra-
tional to summarize that there may be a strong basis to partly
conclude that Fe2þ evoke a deleterious effect on the activity of the
pump through direct and indirect mechanisms as earlier reported
[11].
Moreso, it is a common knowledge that Fe2þ can ultimately
generate the highly reactive OH, and that this reactive oxygen
species can attack proteins and ultimately damage several amino
acid residues, including histidine, tryptophan, cysteine, proline,
methionine, arginine and lysine. Hence, oxidative damage to sev-
eral of these amino acid residues and/or to the peptide backbone
of proteins has been reported to generate carbonyl products
[48,54]. Thus the activity of the enzyme can also be compromised
under direct assault of OH. Sufﬁce to mention that the
T.I. Omotayo et al. / Redox Biology 4 (2015) 234–241240quantiﬁcation of these carbonyl products was not a component of
this study and may be a subject of future research.
However, Esterbauer et al. [55] have observed that the de-
gradation products of lipid peroxidation process can have direct
effect on the activity of enzyme protein molecule. Basically, lipid
peroxidation products are mainly aldehydic products and can be
generally quantiﬁed by reacting them with thiobarbituric acid to
give a purple/pink colour. Among the aldehydic products, mal-
ondialdehyde (MDA) have been widely reported as the key alde-
hyde. Therefore, the study sought to also investigate the possible
effect of malondialdehyde on the activity of the cerebral pump. As
presented in Fig. 5 (panel a), MDA signiﬁcantly inhibited the ac-
tivity of the cerebral sodium pump in a concentration dependent
manner. Further study also reveals that the inhibitory effect of
MDA on the activity of the pump was not protected by the dithiol
(Fig. 5, panel b).
In conclusion, within the limit of our present data and fol-
lowing the arguments thus far, it is apparent that the low activity
of the pump in degenerative diseases mediated by Fe2þ may in-
volve complex multi-component mechanisms which may partly
involve an initial oxidation of the critical thiols of the enzyme
directly mediated by Fe2þ . To the best of our knowledge, this fact
has not been presented in the literature. In addition, however, the
transition metal may also assault membrane lipids and thus evoke
an altered membrane ﬂuidity which ultimately leads to altered
structural arrangement of the cerebral sodium pump with a con-
comitant loss or reduced activity of the enzyme. However, during
severe oxidative-stress mediated progression of such degenerative
diseases; aldehydic products of lipid peroxidation such as MDA
may further exacerbate deleterious effect of Fe2þ by a mechanism
that is likely not related to the oxidation of the essential thiols of
the ouabain-sensitive cerebral electrogenic pump.Acknowledgements
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